EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling

[1]  K. Hu,et al.  mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review). , 2016, Oncology reports.

[2]  F. V. Winck,et al.  EEF1D modulates proliferation and epithelial-mesenchymal transition in oral squamous cell carcinoma. , 2016, Clinical science.

[3]  Xian-Jun Qu,et al.  Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  Y. Qi,et al.  MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R , 2016, Cellular Physiology and Biochemistry.

[5]  J. Mayerson,et al.  Osteosarcoma: A Meta-Analysis and Review of the Literature. , 2015, American journal of orthopedics.

[6]  Rui-peng Song,et al.  P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway. , 2015, International journal of surgery.

[7]  W. Liang,et al.  Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study. , 2015, International journal of clinical and experimental pathology.

[8]  Hong Zhu,et al.  The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma , 2015, Cellular Physiology and Biochemistry.

[9]  N. Sang,et al.  DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas , 2015, Journal of experimental & clinical cancer research : CR.

[10]  J. Lancaster,et al.  BAD-mediated apoptotic pathway is associated with human cancer development , 2015, International journal of molecular medicine.

[11]  A. El'skaya,et al.  Independent overexpression of the subunits of translation elongation factor complex eEF1H in human lung cancer , 2014, BMC Cancer.

[12]  Q. Shi,et al.  CacyBP/SIP protein is important for the proliferation of human glioma cells , 2014, IUBMB life.

[13]  Sang-Muk Oh,et al.  Oxidative stress-induced cyclin D1 depletion and its role in cell cycle processing. , 2013, Biochimica et biophysica acta.

[14]  Liangfang Shen,et al.  Comparative proteomic study for profiling differentially expressed proteins between Chinese left‐ and right‐sided colon cancers , 2013, Cancer science.

[15]  T. Kinzy,et al.  The many roles of the eukaryotic elongation factor 1 complex , 2012, Wiley interdisciplinary reviews. RNA.

[16]  J. Lancaster,et al.  BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin , 2012, Journal of gynecologic oncology.

[17]  James S. Duncan,et al.  Unbiased Functional Proteomics Strategy for Protein Kinase Inhibitor Validation and Identification of bona fide Protein Kinase Substrates: Application to Identification of EEF1D as a Substrate for CK2 , 2011, Journal of proteome research.

[18]  S. Eschrich,et al.  BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival , 2011, Clinical Cancer Research.

[19]  K. Tomizawa,et al.  Transformation of eEF1Bδ into heat‐shock response transcription factor by alternative splicing , 2011, EMBO reports.

[20]  O. Elroy-Stein,et al.  Mitotic Modulation of Translation Elongation Factor 1 Leads to Hindered tRNA Delivery to Ribosomes* , 2011, The Journal of Biological Chemistry.

[21]  Hui-ling Wu,et al.  Eukaryotic translation elongation factor 1 delta inhibits the ubiquitin ligase activity of SIAH-1 , 2011, Molecular and Cellular Biochemistry.

[22]  C. Pan,et al.  Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder , 2011, Histopathology.

[23]  A. El'skaya,et al.  Unbalanced expression of the translation complex eEF1 subunits in human cardioesophageal carcinoma , 2011, European journal of clinical investigation.

[24]  S. Pitson,et al.  Guanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesis , 2011, Oncogene.

[25]  Nadav S. Bar,et al.  Analysis of protein synthesis dynamic model in eukaryotic cells: Input control. , 2009, Mathematical biosciences.

[26]  M. Henry,et al.  Proteomic analysis of multidrug‐resistance mechanisms in adriamycin‐resistant variants of DLKP, a squamous lung cancer cell line , 2009, Proteomics.

[27]  T. Kinzy,et al.  Coordination of Eukaryotic Translation Elongation Factor 1A (eEF1A) Function in Actin Organization and Translation Elongation by the Guanine Nucleotide Exchange Factor eEF1Bα* , 2009, Journal of Biological Chemistry.

[28]  D. Litchfield,et al.  Evidence for Regulation of Mitotic Progression through Temporal Phosphorylation and Dephosphorylation of CK2α , 2009, Molecular and Cellular Biology.

[29]  Orna Elroy-Stein,et al.  Ribosomal Slowdown Mediates Translational Arrest during Cellular Division , 2007, Molecular and Cellular Biology.

[30]  S. Pomeroy,et al.  Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8 , 2006, BMC Cancer.

[31]  M. Al-Maghrebi,et al.  Up-regulation of eukaryotic elongation factor-1 subunits in breast carcinoma. , 2005, Anticancer research.

[32]  E. Pignotti,et al.  Twenty-Year Follow-Up of Osteosarcoma of the Extremity Treated with Adjuvant Chemotherapy , 2004, Journal of chemotherapy.

[33]  Kentaro Kato,et al.  Conserved Protein Kinases Encoded by Herpesviruses and Cellular Protein Kinase cdc2 Target the Same Phosphorylation Site in Eukaryotic Elongation Factor 1δ , 2003, Journal of Virology.

[34]  T. E. Dever,et al.  Gene-Specific Regulation by General Translation Factors , 2002, Cell.

[35]  P. Joseph,et al.  Oncogenic Potential of Mouse Translation Elongation Factor-1δ, a Novel Cadmium-responsive Proto-oncogene* , 2002, The Journal of Biological Chemistry.

[36]  B. Widhe,et al.  Initial Symptoms and Clinical Features in Osteosarcoma and Ewing Sarcoma* , 2000, The Journal of bone and joint surgery. American volume.

[37]  Jai-Sing Yang,et al.  Curcumin-loaded nanoparticles enhance apoptotic cell death of U2OS human osteosarcoma cells through the Akt-Bad signaling pathway. , 2014, International journal of oncology.

[38]  M. Lammi,et al.  Proteomics of chondrocytes with special reference to phosphorylation changes of proteins in stretched human chondrosarcoma cells. , 2008, Biorheology.

[39]  A. Giordano,et al.  Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. , 1995, Critical reviews in eukaryotic gene expression.